Back to search
FDAFDA · Food and drugs·Recall number D-0917-2017

Human Chorionic Gonadotropin, 125 IU HCG, in 0.5 ml syringe, subcutaneous administration, Rx only, Complete Pharmacy & Medical Solutions, Miami Lakes, FL 33014

Published June 21, 2017 · Recall initiated: December 29, 2015

Summary

FDA records drug Class I recall D-0917-2017, published June 21, 2017 and initiated December 29, 2015. Recalling firm: Complete Pharmacy and Medical Solutions LLC; Status: Ongoing; Reported quantity: 1890 syringes; Lot: Lot # 2079ps5, Exp 02/01/2016. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-sterility: presence of mold confirmed by outside laboratory at the 14 day culture.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Complete Pharmacy and Medical Solutions LLC
Distributor
Distributed throughout Florida
Lot
Lot # 2079ps5, Exp 02/01/2016
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Human Chorionic Gonadotropin, 125 IU HCG, in 0.5 ml syringe, subcutaneous administration, Rx only, Complete Pharmacy & Medical Solutions, Miami Lakes, FL 33014 recalled?

Yes. FDA published recall D-0917-2017 on June 21, 2017. Reported hazard: Non-sterility: presence of mold confirmed by outside laboratory at the 14 day culture.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail